New pilot projects to speed progress against ovarian cancer
Developmental Research Program
This program funds small, early-stage projects aimed at finding better ways to detect, understand, and treat ovarian cancer for patients and communities affected by it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11194343 on NIH RePORTER |
What this research studies
From a patient perspective, this program supports short-term pilot projects that try out bold new ideas for ovarian cancer care. It brings together teams at Johns Hopkins, the University of Pennsylvania, and the Wistar Institute and uses a scientific review committee to pick projects that could move quickly toward clinical use. Selected projects receive modest annual funding to generate data, develop methods, or test early-stage diagnostics or therapies that could lead to larger trials. The goal is to spark collaborations and give promising ideas a chance to prove they can help people with ovarian cancer.
Who could benefit from this research
Good fit: People with ovarian cancer or those at high risk for ovarian cancer could become candidates for future trials or sample-based studies that grow out of these pilot projects.
Not a fit: People without ovarian cancer or whose medical needs are unrelated to the specific pilot projects are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, the program could accelerate development of better early-detection tests, targeted treatments, or clinical trials that help people with ovarian cancer live longer and feel better.
How similar studies have performed: The SPORE/Developmental Program model has a track record of launching promising translational projects, though each pilot is early-stage and not guaranteed to succeed.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Wang, Tian-Li — Johns Hopkins University
- Study coordinator: Wang, Tian-Li
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.